Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comprehensive DNA Methylation Profiling of Inflammatory and Non-Inflammatory Mucosa in Crohn's Disease

NCT03272152 is registered in ClinicalTrials.gov with Jinling Hospital, China as lead sponsor.

NCT NCT03272152
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03272152 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comprehensive DNA Methylation Profiling of Inflammatory and Non-Inflammatory Mucosa in Crohn's Disease
Lead sponsor
Jinling Hospital, China
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2017
Completion date
September 30, 2017
Enrollment
14 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

crohn disease, illumina human methylation 850k beadchip, methylation